BriaCell Therapeutics Corp. Share Price
NASDAQ: BCTX | Micro CapBriaCell Therapeutics Corp. Stock Performance
Open $3.74 | Prev. Close $3.71 | Circuit Range N/A |
Day Range $3.68 - $3.75 | Year Range $2.60 - $13.78 | Volume 5,233 |
Average Traded $3.73 |
BriaCell Therapeutics Corp. Share Price Today
As of 29 August 2026, BriaCell Therapeutics Corp.'s share price is $3.73. The stock opened at $3.74, compared to its previous close of $3.71. During today's trading session, BriaCell Therapeutics Corp.'s share price traded between $3.68 and $3.75, with an average price of $3.71. Over the past 52 weeks, the stock has recorded a high of $13.78 and a low of $2.60. In terms of performance, BriaCell Therapeutics Corp.'s share price has declined by 1.45% over the last six months and is down 51.99% on a year-on-year basis.
BriaCell Therapeutics Corp. Share Price Chart
BriaCell Therapeutics Corp. Stock Fundamentals & Key Indicators
Market Cap $1.58M | PE Ratio (TTM) -0.06 | Dividend Yield N/A |
EPS (TTM) $-62.19 | Revenue (TTM) N/A | Return On Equity (TTM) -153.20% |
Profit Margin N/A | Debt to Equity 0.23 | Quarterly Earnings Growth YoY -14.79% |
BriaCell Therapeutics Corp. Quarterly Profit & Loss
All figures in USD
BriaCell Therapeutics Corp. Annual Profit & Loss
All figures in USD
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.40 | $3.74 | +3.89% |
Jul 2026 | $3.40 | $3.60 | +10.60% |
Jun 2026 | $3.27 | $3.25 | -9.83% |
May 2026 | $4.25 | $3.61 | -13.64% |
Apr 2026 | $4.22 | $4.18 | -0.48% |
Mar 2026 | $3.69 | $4.20 | +10.82% |
Feb 2026 | $4.28 | $3.79 | -11.96% |
Jan 2026 | $7.06 | $4.30 | -39.71% |
Dec 2025 | $12.29 | $7.14 | -26.39% |
Nov 2025 | $10.14 | $9.70 | -18.01% |
Oct 2025 | $11.40 | $11.83 | +9.44% |
Sep 2025 | $7.84 | $10.81 | +38.95% |
BCTX Share Price FAQs
What is BriaCell Therapeutics Corp. share price today?
What is the 52 week high and 52 week low of BriaCell Therapeutics Corp. stock?
What is BCTX's market capitalisation today?
What is BCTX's net income for the last quarter?
What is the 5 year returns of BCTX?
What is the high & low stock price of BCTX today?
Can I buy BCTX shares in India?